Skip to main content
Explore URMC
menu

Steven D. Wittlin, M.D.

Contact Information

Phone Numbers

Office: (585) 275-2901

Fax: (585) 273-1288

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting

Endocrinology

Biography

Dr. Wittlin received his M.D. from Tel Aviv University with honors. He then completed his residency training in internal medicine at Booth Memorial Medical Center, followed by an endocrinology fellowship at New York University Medical Center. He served as Chief of Endocrinology and subsequently Assistant Chairman of Medicine at Booth Memorial Medical Center for a twelve-year period. He moved to Rochester in 1993. Dr. Wittlin's major clinical interest, apart from general endocrinology, is treatment of diabetes, especially new modalities of therapy with an emphasis on insulin pumps and continuous glucose monitoring. His research interests have mainly focused on novel diabetes treatments, preservation of beta cell function, new modalities for assessing diabetes and postprandial glucose control, and assessment of cardiovascular risk in diabetes.

Professional Background

Clinical Director, Endocrine-Metabolism Division and Director, Diabetes Service
Dr. Wittlin received his M.D. from Tel Aviv University with honors. He then completed his residency training in internal medicine at Booth Memorial Medical Center, followed by an endocrinology fellowship at New York University Medical Center. He served as Chief of Endocrinology and subsequently Assistant Chairman of Medicine at Booth Memorial Medical Center for a twelve-year period. He moved to Rochester in 1993. Dr. Wittlin's major clinical interest, apart from general endocrinology, is treatment of diabetes, especially new modalities of therapy with an emphasis on insulin pumps and continuous glucose monitoring. His research interests have mainly focused on novel diabetes treatments, preservation of beta cell function, new modalities for assessing diabetes and postprandial glucose control, and assessment of cardiovascular risk in diabetes.

Credentials

Education

1975
MD | Sackler School of Medicine (Tel Aviv University)

Post-doctoral Training & Residency

07/01/1979 - 06/30/1981
Fellowship in Internal Medicine, Endocrinology, Diabetes & Metabolism at New York University Langone Medical Center-GME

01/01/1977 - 06/30/1979
Residency in Internal Medicine at New York Hospital Medical Center of Queens

01/01/1976 - 12/31/1976
Internship in Internal Medicine at New York Hospital Medical Center of Queens

VIEW ALL expand_more

Publications

Journal Articles

2/5/2018
Naqvi SY, Wittlin SD, Schwartz RG. "Refining risk in diabetes and CAD with SPECT MPI: New insights and future challenges." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.. 2018 Feb 5; Epub 2018 Feb 05.

5/2017
Forrestel AC, Miedlich SU, Yurcheshen M, Wittlin SD, Sellix MT. "Chronomedicine and type 2 diabetes: shining some light on melatonin." Diabetologia.. 2017 May; 60(5):808-822. Epub 2016 Dec 16.

2014
Choudhary N, Chen L, Kotyra L, Wittlin SD, Alexis JD. "Improvement in glycemic control after left ventricular assist device implantation in advanced heart failure patients with diabetes mellitus." ASAIO journal : a peer-reviewed journal of the American Society for Artificial Internal Organs.. 2014 60(6):675-80.

VIEW ALL PUBLICATIONS

Videos

play_circle_filled

Diabetes Rates Double in Just Three Decades